Literature DB >> 20416362

The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice.

A M Jenner1, W L F Lim, M P E Ng, M R Wenk, G Shui, M J Sharman, S E Gandy, R N Martins.   

Abstract

Despite apolipoprotein E's important role in cholesterol transport and metabolism in the brain as well as its influence on Alzheimer's disease, the impact of the human APOE genotype on cholesterol metabolism in brain has not been fully examined. This study was carried out to investigate APOE genotype effects on oxysterols measured. In this study the measurement of cholesterol and several oxysterols in the brains of human APOE epsilon2, epsilon3 and epsilon4 knock-in mice at 8 weeks and 1 year of age using gas chromatography mass spectrometry (GC-MS) demonstrated no APOE genotype or age effect on total brain cholesterol and the oxysterol 24-hydroxycholesterol. The level of 27-hydroxycholesterol was elevated in 1 year old animals for all APOE genotypes. Interestingly, lathosterol an indicator of cholesterol synthesis was significantly reduced in the 1 year old animals for all APOE genotypes. APOE epsilon4 expressing mice exhibited statistically lower levels of lathosterol compared to APOE epsilon2 in both the young and old mice. Oxidized cholesterol metabolites were significantly lower in APOE epsilon2 mice compared to other genotypes at 8 weeks old. Although minimal differences were observed between APOE E3 and E4 knock-in (KI) mice, these findings indicate that there are some clear APOE genotype specific effects on brain cholesterol synthesis and associated metabolic pathways, particularly in APOE epsilon2 KI mice. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416362      PMCID: PMC3991300          DOI: 10.1016/j.neuroscience.2010.04.026

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  31 in total

1.  Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide.

Authors:  D Paris; T Town; T A Parker; J Humphrey; M Mullan
Journal:  Neurosci Lett       Date:  1998-11-06       Impact factor: 3.046

2.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice.

Authors:  C Knouff; M E Hinsdale; H Mezdour; M K Altenburg; M Watanabe; S H Quarfordt; P M Sullivan; N Maeda
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Cholesterol synthesis rate in human hippocampus declines with aging.

Authors:  K M Thelen; P Falkai; T A Bayer; D Lütjohann
Journal:  Neurosci Lett       Date:  2006-05-15       Impact factor: 3.046

4.  LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.

Authors:  Susan J Murdoch; Andrew P Boright; Andrew D Paterson; Bernard Zinman; Michael Steffes; Patricia Cleary; Karen Edwards; Santica S Marcovina; Jonathan Q Purnell; John D Brunzell
Journal:  Atherosclerosis       Date:  2006-06-05       Impact factor: 5.162

Review 5.  Oxysterols and Alzheimer's disease.

Authors:  I Björkhem; M Heverin; V Leoni; S Meaney; U Diczfalusy
Journal:  Acta Neurol Scand Suppl       Date:  2006

Review 6.  Oxysterols, cholesterol homeostasis, and Alzheimer disease.

Authors:  Jacob Vaya; Hyman M Schipper
Journal:  J Neurochem       Date:  2007-06-15       Impact factor: 5.372

7.  Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.

Authors:  Marjan Shafaati; Alina Solomon; Miia Kivipelto; Ingemar Björkhem; Valerio Leoni
Journal:  Neurosci Lett       Date:  2007-08-15       Impact factor: 3.046

8.  Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample.

Authors:  Chung-Yung J Lee; Shan Hong Huang; Andrew M Jenner; Barry Halliwell
Journal:  Free Radic Biol Med       Date:  2007-12-27       Impact factor: 7.376

9.  Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid.

Authors:  Steve Meaney; Maura Heverin; Ute Panzenboeck; Lena Ekström; Magnus Axelsson; Ulla Andersson; Ulf Diczfalusy; Irina Pikuleva; John Wahren; Wolfgang Sattler; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2007-01-24       Impact factor: 5.922

10.  Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.

Authors:  Marta Valenza; Jeffrey B Carroll; Valerio Leoni; Lisa N Bertram; Ingeman Björkhem; Roshni R Singaraja; Stefano Di Donato; Dieter Lutjohann; Michael R Hayden; Elena Cattaneo
Journal:  Hum Mol Genet       Date:  2007-07-05       Impact factor: 6.150

View more
  10 in total

1.  Decreased content, rate of synthesis and export of cholesterol in the brain of apoE knockout mice.

Authors:  Valéria Sutti Nunes; Patrícia Miralda Cazita; Sérgio Catanozi; Edna Regina Nakandakare; Eder Carlos Rocha Quintão
Journal:  J Bioenerg Biomembr       Date:  2018-04-20       Impact factor: 2.945

2.  Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.

Authors:  Stephen Arold; Patrick Sullivan; Tina Bilousova; Edmond Teng; Carol A Miller; Wayne W Poon; Harry V Vinters; Lindsey B Cornwell; Tommy Saing; Gregory M Cole; Karen Hoppens Gylys
Journal:  Acta Neuropathol       Date:  2011-10-22       Impact factor: 17.088

3.  On the regulatory role of side-chain hydroxylated oxysterols in the brain. Lessons from CYP27A1 transgenic and Cyp27a1(-/-) mice.

Authors:  Zeina Ali; Maura Heverin; Maria Olin; Jure Acimovic; Anita Lövgren-Sandblom; Marjan Shafaati; Ann Båvner; Vardiella Meiner; Eran Leitersdorf; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2013-01-02       Impact factor: 5.922

Review 4.  Oxidized cholesterol as the driving force behind the development of Alzheimer's disease.

Authors:  Paola Gamba; Gabriella Testa; Simona Gargiulo; Erica Staurenghi; Giuseppe Poli; Gabriella Leonarduzzi
Journal:  Front Aging Neurosci       Date:  2015-06-19       Impact factor: 5.750

5.  Relationship between oxysterols and mild cognitive impairment in the elderly: a case-control study.

Authors:  Quanri Liu; Yu An; Huanling Yu; Yanhui Lu; Lingli Feng; Chao Wang; Rong Xiao
Journal:  Lipids Health Dis       Date:  2016-10-10       Impact factor: 3.876

Review 6.  Oxidative stress and the amyloid beta peptide in Alzheimer's disease.

Authors:  C Cheignon; M Tomas; D Bonnefont-Rousselot; P Faller; C Hureau; F Collin
Journal:  Redox Biol       Date:  2017-10-18       Impact factor: 11.799

7.  Cholesterol metabolism in aging simultaneously altered in liver and nervous system.

Authors:  Valéria Sutti Nunes; Guilherme da Silva Ferreira; Eder Carlos Rocha Quintão
Journal:  Aging (Albany NY)       Date:  2022-02-07       Impact factor: 5.682

8.  Apolipoprotein E Isoform-specific changes related to stress and trauma exposure.

Authors:  Eileen Ruth S Torres; Jenny Luo; James K Boehnlein; Daniel Towns; J David Kinzie; Andrea E DeBarber; Jacob Raber
Journal:  Transl Psychiatry       Date:  2022-03-28       Impact factor: 6.222

9.  Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice.

Authors:  Tiago Gil Oliveira; Tal Nuriel; André Miguel Miranda; Archana Ashok; Robin Barry Chan; Bowen Zhou; Yimeng Xu; Laura Beth McIntire; Estela Area-Gomez; Gilbert Di Paolo; Karen E Duff
Journal:  Transl Psychiatry       Date:  2022-03-29       Impact factor: 7.989

10.  Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles.

Authors:  Rosie M Walker; Kadi Vaher; Mairead L Bermingham; Stewart W Morris; Andrew D Bretherick; Yanni Zeng; Konrad Rawlik; Carmen Amador; Archie Campbell; Chris S Haley; Caroline Hayward; David J Porteous; Andrew M McIntosh; Riccardo E Marioni; Kathryn L Evans
Journal:  Genome Med       Date:  2021-01-04       Impact factor: 11.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.